393 related articles for article (PubMed ID: 20463012)
1. Hyaluronan stabilizes focal adhesions, filopodia, and the proliferative phenotype in esophageal squamous carcinoma cells.
Twarock S; Tammi MI; Savani RC; Fischer JW
J Biol Chem; 2010 Jul; 285(30):23276-84. PubMed ID: 20463012
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of oesophageal squamous cell carcinoma progression by in vivo targeting of hyaluronan synthesis.
Twarock S; Freudenberger T; Poscher E; Dai G; Jannasch K; Dullin C; Alves F; Prenzel K; Knoefel WT; Stoecklein NH; Savani RC; Homey B; Fischer JW
Mol Cancer; 2011 Mar; 10():30. PubMed ID: 21429221
[TBL] [Abstract][Full Text] [Related]
3. Esophageal Squamous Cell Carcinoma Cells Modulate Chemokine Expression and Hyaluronan Synthesis in Fibroblasts.
Kretschmer I; Freudenberger T; Twarock S; Yamaguchi Y; Grandoch M; Fischer JW
J Biol Chem; 2016 Feb; 291(8):4091-106. PubMed ID: 26699196
[TBL] [Abstract][Full Text] [Related]
4. Hyaluronic acid, CD44 and RHAMM regulate myoblast behavior during embryogenesis.
Leng Y; Abdullah A; Wendt MK; Calve S
Matrix Biol; 2019 May; 78-79():236-254. PubMed ID: 30130585
[TBL] [Abstract][Full Text] [Related]
5. Triptolide suppresses the in vitro and in vivo growth of lung cancer cells by targeting hyaluronan-CD44/RHAMM signaling.
Song JM; Molla K; Anandharaj A; Cornax I; O Sullivan MG; Kirtane AR; Panyam J; Kassie F
Oncotarget; 2017 Apr; 8(16):26927-26940. PubMed ID: 28460475
[TBL] [Abstract][Full Text] [Related]
6. Src-/- fibroblasts are defective in their ability to disassemble focal adhesions in response to phorbol ester/hyaluronan treatment.
Hall CL; Wang FS; Turley E
Cell Commun Adhes; 2002; 9(5-6):273-83. PubMed ID: 12745438
[TBL] [Abstract][Full Text] [Related]
7. Tumor-suppressive functions of 4-MU on breast cancer cells of different ER status: Regulation of hyaluronan/HAS2/CD44 and specific matrix effectors.
Karalis TT; Heldin P; Vynios DH; Neill T; Buraschi S; Iozzo RV; Karamanos NK; Skandalis SS
Matrix Biol; 2019 May; 78-79():118-138. PubMed ID: 29673760
[TBL] [Abstract][Full Text] [Related]
8. Role of receptor for hyaluronic acid-mediated motility (RHAMM) in low molecular weight hyaluronan (LMWHA)-mediated fibrosarcoma cell adhesion.
Kouvidi K; Berdiaki A; Nikitovic D; Katonis P; Afratis N; Hascall VC; Karamanos NK; Tzanakakis GN
J Biol Chem; 2011 Nov; 286(44):38509-38520. PubMed ID: 21914806
[TBL] [Abstract][Full Text] [Related]
9. Hyaluronan-CD44/RHAMM interaction-dependent cell proliferation and survival in lung cancer cells.
Song JM; Im J; Nho RS; Han YH; Upadhyaya P; Kassie F
Mol Carcinog; 2019 Mar; 58(3):321-333. PubMed ID: 30365189
[TBL] [Abstract][Full Text] [Related]
10. The impact of the receptor of hyaluronan-mediated motility (RHAMM) on human urothelial transitional cell cancer of the bladder.
Niedworok C; Kretschmer I; Röck K; Vom Dorp F; Szarvas T; Heß J; Freudenberger T; Melchior-Becker A; Rübben H; Fischer JW
PLoS One; 2013; 8(9):e75681. PubMed ID: 24069434
[TBL] [Abstract][Full Text] [Related]
11. 4-Methylumbelliferone Suppresses Hyaluronan Synthesis and Tumor Progression in SCID Mice Intra-abdominally Inoculated With Pancreatic Cancer Cells.
Nagase H; Kudo D; Suto A; Yoshida E; Suto S; Negishi M; Kakizaki I; Hakamada K
Pancreas; 2017 Feb; 46(2):190-197. PubMed ID: 27846148
[TBL] [Abstract][Full Text] [Related]
12. Synthesis of hyaluronan in oesophageal cancer cells is uncoupled from the prostaglandin-cAMP pathway.
Twarock S; Röck K; Sarbia M; Weber AA; Jänicke RU; Fischer JW
Br J Pharmacol; 2009 May; 157(2):234-43. PubMed ID: 19338584
[TBL] [Abstract][Full Text] [Related]
13. Bit1 knockdown contributes to growth suppression as well as the decreases of migration and invasion abilities in esophageal squamous cell carcinoma via suppressing FAK-paxillin pathway.
Fan T; Chen J; Zhang L; Gao P; Hui Y; Xu P; Zhang X; Liu H
Mol Cancer; 2016 Mar; 15():23. PubMed ID: 26956728
[TBL] [Abstract][Full Text] [Related]
14. HAS3-related hyaluronan enhances biological activities necessary for metastasis of osteosarcoma cells.
Tofuku K; Yokouchi M; Murayama T; Minami S; Komiya S
Int J Oncol; 2006 Jul; 29(1):175-83. PubMed ID: 16773198
[TBL] [Abstract][Full Text] [Related]
15. Hyperglycaemia and aberrated insulin signalling stimulate tumour progression via induction of the extracellular matrix component hyaluronan.
Twarock S; Reichert C; Peters U; Gorski DJ; Röck K; Fischer JW
Int J Cancer; 2017 Aug; 141(4):791-804. PubMed ID: 28493326
[TBL] [Abstract][Full Text] [Related]
16. Hyaluronan induces vascular smooth muscle cell migration through RHAMM-mediated PI3K-dependent Rac activation.
Gouëffic Y; Guilluy C; Guérin P; Patra P; Pacaud P; Loirand G
Cardiovasc Res; 2006 Nov; 72(2):339-48. PubMed ID: 16934786
[TBL] [Abstract][Full Text] [Related]
17. Changed lamellipodial extension, adhesion plaques and migration in epidermal keratinocytes containing constitutively expressed sense and antisense hyaluronan synthase 2 (Has2) genes.
Rilla K; Lammi MJ; Sironen R; Törrönen K; Luukkonen M; Hascall VC; Midura RJ; Hyttinen M; Pelkonen J; Tammi M; Tammi R
J Cell Sci; 2002 Sep; 115(Pt 18):3633-43. PubMed ID: 12186949
[TBL] [Abstract][Full Text] [Related]
18. 4-Methylumbelliferone inhibits hyaluronan synthesis by depletion of cellular UDP-glucuronic acid and downregulation of hyaluronan synthase 2 and 3.
Kultti A; Pasonen-Seppänen S; Jauhiainen M; Rilla KJ; Kärnä R; Pyöriä E; Tammi RH; Tammi MI
Exp Cell Res; 2009 Jul; 315(11):1914-23. PubMed ID: 19285976
[TBL] [Abstract][Full Text] [Related]
19. Toll-like receptor 2 (TLR2), transforming growth factor-β, hyaluronan (HA), and receptor for HA-mediated motility (RHAMM) are required for surfactant protein A-stimulated macrophage chemotaxis.
Foley JP; Lam D; Jiang H; Liao J; Cheong N; McDevitt TM; Zaman A; Wright JR; Savani RC
J Biol Chem; 2012 Oct; 287(44):37406-19. PubMed ID: 22948158
[TBL] [Abstract][Full Text] [Related]
20. Oligosaccharides of hyaluronan induce angiogenesis through distinct CD44 and RHAMM-mediated signalling pathways involving Cdc2 and gamma-adducin.
Matou-Nasri S; Gaffney J; Kumar S; Slevin M
Int J Oncol; 2009 Oct; 35(4):761-73. PubMed ID: 19724912
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
